Come up with a name for your new list and we'll add to it:
SARcode Biosciences was acquired by
Shire on March 25, 2013.
SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-c…